Transcriptomic profile of the maternal-fetal interface may reveal
potential protective effects against miscarriage after COVID-19
vaccination
Abstract
Background: Concerns of COVID-19 vaccine safety from pregnant women
still widespread. We used transcriptomic profile analysis to study
changes of the maternal-fetal interface after vaccination and explore
the possible protective effects from vaccination against miscarriage.
Methods: We collected decidual tissuesafter uterine curettage from
pregnant women in the first trimister with (n = 6) and without a
COVID-19 vaccination (n = 6) and performed RNA-sequencing. Furthermore,
we ananlyzed our transcriptome datas of samples and other datasets about
maternal-fetal interface and miscarrige to analyze the potential link by
bioinformatics tools. Results: We identified 879 different expressed
genes from pregnant women who received vaccination and found that the
COVID-19 vaccine could alter some hazardous RSA-related genes, such as
CXCL11, FOS, FOSB, LY96, MMP10, and NCF2. Vaccination also changed some
hazardous RSA-related signaling pathway.These molecules induced the
transformation of M2 macrophages and promoted the balance of Th1/Th2
immune responses. Finally, these effects on the immune microenvironment
of the maternal-fetal interface also showed corresponding positive
changes. Conclusion: Many RSA-related signaling molecules were reversed
after COVID-19 vaccination, indicating that the vaccine did not cause
RSA, and these molecules ultimately may have protective effects on
miscarriage by influencing the immune microenvironment at the
maternal-fetal interface.